Capstone Investment Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,299
Closed -$245K – 1904
2026
Q1
$245K Buy
+1,299
New +$274K ﹤0.01% 1446
2024
Q2
– Sell
-5,496
Closed -$578K – 2470
2024
Q1
$578K Buy
+5,496
New +$494K ﹤0.01% 1477
2017
Q1
– Sell
-34,301
Closed -$509K – 1117
2016
Q4
$509K Buy
+34,301
New +$615K 0.02% 581
2014
Q2
– Sell
-100,000
Closed -$4.28M – 459
2014
Q1
$4.28M Buy
100,000
+66,199
+196% +$2.92M 0.05% 180
2013
Q4
$1.42M Buy
+33,801
New +$1.47M 0.02% 376

Other funds holding THC

Capstone Investment Advisors's THC Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,299 shares — an estimated $245K sold.

Capstone Investment Advisors first reported a position in THC in Q4 2013 and held it in 5 quarters. The position peaked at $4.28M in Q1 2014. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,299 Tenet Healthcare shares in Q2 2026, an estimated $245K.
  • Capstone Investment Advisors first reported a position in Tenet Healthcare in Q4 2013 and held it in 5 quarters.
  • Capstone Investment Advisors's Tenet Healthcare position peaked at $4.28M in Q1 2014.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.